In this week’s video, I sharing what happened to me when I went back to UT Southwestern Medical Center’s William P. Tate University Hospital for my 9th Spinraza injection. This was actually my 5th maintenance dose injection, and I not only share what happened to me, I also give you some advice on how to avoid getting a headache after one of your procedures.
In this week’s video, I discuss how Spinraza may, or may not be helping me. I talk about the differences between the way I felt while receiving my loading dose injections, versus how I feel while going through my maintenance dose injections. The differences may surprise you, and I’m hoping that the information that I give you, will give you information that you can talk to your doctors about.
In this week’s video, I discuss 4 key tips that you should consider before going in for your next Spinraza injection. These 4 tips that I’m sharing with you are what I found to be helpful when preparing myself for any Spinraza injection.
In this week’s video, I discussed the key differences between Biogen’s treatment known as Spinraza, and AveXis’s treatment known as ZOLGENSMA. I not only review the key differences between these 2 treatments, I go into detail about how these 2 treatments work to help those of us with SMA.
In this week’s video, I discussed the recent approval from the FDA of AveXis’s drug known as ZOLGENSMA. The FDA made the official announcement on Friday, May 24, 2019, making ZOLGENSMA the 2ndFDA approved treatment for those of us who suffer from spinal muscular atrophy. I not only discuss the FDA approval of ZOLGENSMA, I also share a document that was written by SMA News Today regarding this historic announcement.
While I only do my videos for my YouTube channel every other week, I’m producing another video this week because of some exciting news regarding AveXis’s drug candidate ZOLGENSMA. We have received information that AveXis has provided additional information to the FDA, and have asked the FDA to broaden the label of their potential new drug therapy. The initial request was for SMA Type 1 infants, who were 9 months of age or younger. Now, AveXis is requesting that the label also include children with SMA Type 2, who are 5 years of age or younger. Since this is exciting news for all of us who have spinal muscular atrophy, I thought I should produce another video to keep everyone updated with regards to the latest news.
In this podcast, I discuss my feelings as to whether or not I feel that Spinraza has done me any good. While many of us are on this treatment, some of us are receiving better benefits than others, and with the potential approval of another FDA approved treatment coming in May or June of this year, those of us that are on Spinraza, will start to see choices with regards to treatments for our disease.
In this podcast, I discuss the topic that is very important in my life. While I never try to preach my Christianity to any of my subscribers or followers, my belief in God is a subject that I’m not afraid to talk about. Growing up in a Christian household, taught me the importance of my faith and while I don’t necessarily talk about it on my YouTube channel or my other social media and multimedia accounts, it’s still a subject that I put first in my life. I had something that happened to me not too long ago that caused me to think about my faith, and I wanted to share this story with you so that you could fully understand why I believe in God and his son, my Lord and Savior Jesus Christ. This podcast is not meant to push my religion on anybody that decides to listen to it, but please understand that my faith will always come first in my life and that everything else must take a backseat with regards to importance.
In this podcast, I discuss whether or not Spinraza should be considered a cure or a treatment. The word cure is being tossed around regarding Biogen’s drug Spinraza. In my opinion, this word is being passed around to quickly and to easily, and those of us that are on active treatment with Spinraza, need to understand the differences between these two words. In my podcast, I give my opinions as to what I believe Spinraza should be considered.
In today’s podcast, I would like to read an article that was released from Avexis pharmaceuticals on October 18, 2018. Avexis pharmaceuticals is in the process of filing for FDA approval for their drug known as AVXS-101. For quite some time now, Avexis has been going through clinical trials of their drug AVXS-101, and some of the results that Avexis has received from these clinical trials have been dramatic to say the least. This filing for FDA approval is just another example of what I’ve been speaking about for the past year. I’ve been saying that we, as SMA patients have a lot to look forward to and I’ve also stated many times that I felt like there would be multiple treatments that would become available sometime within 2019. I’m going to be reading verbatim from this article, and I will also link this article in the description of my podcast so that you can click on the link and view the article for yourself.
In this podcast, I’m doing my first podcast interview for BioNews Services. I was recently offered a full-time position with BioNews Services as their Forums Director. Every once in a while, I get to do podcast interviews with individuals who are active within the SMA community. Anytime I do a podcast interview for BioNews Services, I will include them in my SoundCloud account for those who are following me in my podcast series. In today’s interview, I am speaking with Shawn Smith. Shawn recently had an SIC port implanted in his body so that he could receive his Spinraza treatments. SIC is an acronym that stands for Subcutaneous Intrathecal Catheter. This port is being tested on SMA patients to see if this would make it easier for us to receive our treatments that we must go through for the rest of our lives. Shawn gives first-hand knowledge of this SIC port, and also gives valuable information for those of us who are considering talking to our doctors about this medical device.
This website was created by smajourney51 and its developer, Michael P. Morale. The name smajourney51 and its corresponding logo are not to be used in any other website, YouTube channel or any other social media account without the express written consent of smajourney51. No videos on the smajourney51.com website or the smajourney51 YouTube channel are to be used in any other website, YouTube channel or any other social media account without the express written consent of smajourney51. All links, videos, graphics, personal opinions and advice are meant for informational purposes only. Subscribers and followers to my website, YouTube channel, Facebook page, Twitter account and Instagram account should consult their personal physician for any medical advice. The information that I provide in the above listed social media sites are my own personal opinion, and should not be used by any of my subscribers and followers when making medical decisions.